Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INTERVENT is a physician-led, technology-driven healthcare company focused on behavior change, lifestyle management, and population health management rather than drug development. The company develops, licenses, and delivers evidence-based programs, assessments, coaching, and digital tools for prevention and management of cardiovascular and other chronic diseases. Its services are delivered primarily through digital and telehealth approaches and are used by employers, healthcare providers, health insurers, pharmaceutical companies, device manufacturers, and individual consumers. INTERVENT also operates health and wellness coach training and education programs and has supported large clinical-trial lifestyle intervention components such as SAMMPRIS and CREST-2. The business appears to be an active commercial healthcare services company, not a biotech or pharma therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INTERVENT International.